AllDocs -> cancers

A210 : Thyroid cancer tissues (formalin fixed) For research use only Specifications: • No. of cases: 33 • Tissue type: Thyroid cancer tissues • No. of spots: 2 spots from each cancer case (66 spots) 4 non-neoplastic spots (4 spots) • Total spots: 70 • Corresponding normal tissues with cancers: Yes • Diameter: 1. 0 mm Documents : • Product specification: layout, summary of tissue spots • H&E stained images • Detailed pathological information Layout: Page 2 Summary of tissue spots A210 : Thyroid cancer tissues (formalin fixed) For research use only No. Sex Age Key Word Surgery TNM Stage 1 1, 2 f 49 thyroid gland: papillary carcinoma dissection T3N1aM0 2 3, 4 f 48 thyroid gland: ...

www.ljm.org.ly Libyan J Med, AOP:060514 1 Cite this article as: Libyan J Med, AOP:060514 (published 6 June 2006) Update on epidemiology classification, and management of thyroid cancer ABC article Heitham Gheriani, MD, FRCS (I), FRCS (Ed) HNS Department, St Vincent University Hospital, Elm Park, Dublin 4, Ireland. Received for publication on 23 Jan 2006. Accepted in revised form on 03 May 2006. INTRODUCTION Thyroid cancer represents approximately 0.5–1% of all human malignancy 1 . In the UK the incidence of thyroid cancer is 2-3 per 100,000 populations 2 . In geographical areas of low iodine intake and in areas exposed to nuclear disasters the incidence of thyroid cancer is higher. Benign thyroid conditions are much more common. In the UK approximately 8 % of the population ...

ANAPLASTIC THYROID CANCER Sam J. Cunningham, MD, PhD Francis B. Quinn, Jr., MD UTMB Dept of Otolaryngology May 11, 2005 Page 2 Anaplastic Thyroid Cancer (APC) One of the most aggressive malignancies Survival measured in months Rare (2 per million per year) 1.6% of all thyroid cancers Often associated with well differentiated thyroid cancers (evidence of dedifferentiation, <1%) History Path Incidence declining IHC staining in ’80s Iodination of food More aggressive treatment on WDTC Page 3 Clinical Presentation 60’s-70’s 55-77% female Most patients present with rapidly enlarging neck mass (mean size at presentation 8cm) Some incidentally discovered Local compressive symptoms Cervical lymphadenopathy in >40% 30% with TVC paralysis ...

In Pennsylvania, the average annual (1998-2002) age-adjusted incidence rate for thyroid cancer among females was nearly three times the rate for males (14.9 per 100,000 versus 5.0, respectively). The average annual rate for white females (15.1 per 100,000) was nearly 25 percent higher than the rate for black females (12.1). Thyroid cancer is one of the rarer types. However, the annual age-adjusted incidence rates have been rising dramatically among both males and females. In 2002, the 1,591 cases of invasive thyroid cancer was the highest number ever reported to the Pennsylvania Cancer Registry. The 2002 age-adjusted incidence rate (12.3 per 100,000) was over twice as high as the 1993 rate (5.3). Higher incidence rates among females suggest the role of hormonal factors in the etiology. Almost 29 percent of the invasive thyroid cancer cases diagnosed between 1998 and 2002 occurred among residents under 40 years of age. Approximately ...

Cancer of the Thyroid The thyroid is a gland located in the front and sides of the neck. It produces hormones that are key for normal growth and for controlling the normal rate of activity of almost every system in the body. Unfortunately, some people will develop a small lump within the thyroid , called a thyroid nodule. Nodules in the thyroid gland may be found in as many as five to ten percent of the general population and are three times more common in women than men. Though most thyroid nodules are harmless, between five to ten percent of all thyroid nodules turn out to be cancerous. Although there is no known reason why a thyroid nodule will develop in the first place, we do know that people who have received radiation treatment to the face, neck, or chest have a greater risk for developing thyroid nodules later. In fact, one-third of thyroid nodules found in such people may be cancerous. ...

THYROID CANCER I. Introduction There are over 11,000 new cases of thyroid cancer each year in the US. Females are more likely to have thyroid cancer than men by a ratio of 3:1, and it is more common in people who have been treated with radiation to the head, neck, or chest, most often for benign conditions (although radiation treatment for benign conditions is no longer carried out). Thyroid cancer can occur in any age group, although it is most common after age 30 and its aggressiveness increases significantly in older patients. Rather than causing the whole thyroid gland to enlarge, a cancer usually causes small growths (nodules) within the thyroid . Although as many as 10% of the population will have thyroid nodules, the vast majority are benign. Only approximately 5% of all thyroid nodules are malignant. Nodules are more likely to be cancerous if only one nodule is found rather than ...

242 MJA Vol 180 1 March 2004 Endocrinology MJ A Practice Essentials The Medical Journal of Australia ISSN: 0025-729X 1 March 2004 180 5 242-247 ©The Medical Journal of Australia 2004 www.mja.com.au MJA Practice Essentials – Endocrinology Thyroid nodules are very common, but have a relatively low risk of malignancy T HYROID NODULES ARE COMMON and of concern because of the risk of malignancy and hyperfunction. The incidence of papillary thyroid cancer appears to be increasing, both in Australia and worldwide. 1 While some of this increase is due to detection of small lesions by sensitive diagnostic tests such as ultrasonography, there also seems to be an increase in larger lesions. The cause of this is unknown. Epidemiology The reported prevalence of thyroid nodules varies with the ...

Radiation Therapy & Thyroid Cancer Page 2 Radiation Therapy • External beam * • Intracavitary/brachytherapy • Interstitial • Radiopharmaceutical * Page 3 External Beam • Different machines for different tumour locations • Usually a series of treatments - multiple fractions per course • Each fraction takes only minutes Page 4 Systemic Radiotherapy • Radioactive iodine p.o.* • Radioactive phosporous intra-peritoneal • Labeled radioactive antibodies - undergoing research Page 5 Radioactive Iodine I131 • Beta particles mostly • Physical half life 8 days • Biologic half life varies: 4 days to 17 hours • Dose given varies from 30 mCi to 200 mCi • ...

Steven Waguespack, MD Sam Wells, MD Julie Ross, PhD Archie Bleyer, MD Chapter 12 Thyroid Cancer Cancer in 15- to 29-Year-Olds in the United States Page 2 CHAPTER 12 THYROID CANCER SEER AYA Monograph 144 National Cancer Institute HIGHLIGHTS Incidence • In the United States from 1975 to 2000, thyroid cancer accounted for about 10% of all malignancies diagnosed in individuals 15 to 29 years of age and was the 4th most common cancer in this age group. • Nearly 2,400 individuals 15 to 29 years of age were diagnosed with a malignant thyroid neoplasm in the U.S. during the year 2000. • Thyroid ...

Chapter 18b. Thyroid Cancer Presentation of this chapter is supported in part by Genzyme , the makers of rhTSH (THY- ROGEN) Incidence and Distribution The annual incidence of thyroid cancer varies considerably in different registries, ranging from 1.2-2.6 per 100,000 individuals in men and from 2.0-3.8 per 100,000 in women (92, 93). It is particularly elevated in Iceland and Hawaii, being nearly two times higher than in North European countries, Canada and the USA. In Hawaii, the incidence rate of thyroid cancer in each ethnic group is higher than that registered in their country of origin (94), and it is particularly common among Chinese males and Filipino females. Most of the differences are probably due to ethnic or environ- mental factors (such as spontaneous background radiation) or dietary habits (95), but different standards of medical expertise and health care may also play a role ...

D ATA S HEET Rev 010406B Thyroid Cancer Marker Mouse Monoclonal Antibody Cat. #MS-1914-S0, -S1, or -S (0.1ml, 0.5ml, or 1.0ml Supernatant) Cat. #MS-1914-R7 (7.0ml) (Ready-to-Use for Immunohistochemical Staining) 47777 Warm Springs Blvd. Fremont CA 94539 USA Tel: (800) 828-1628 Fax: (510) 991-2826 Email: labvision@labvision.com Website: www.labvision.com Description: Papillary carcinoma is by far the most frequent malignant tumor of the thyroid with a threefold prevelance in females. Studies have shown that 100% of malignant thyroid lesions were found to contain the keratan sulfate (KS) bearing molecules, while these were virtually absent from benign tissues and other thyroid tumors, with the exception of 21% of follicular carcinoma cases analyzed 1 . Clone 373E1 is specific ...

l del file contenuto in http://users.ox.ac.uk/~worc1440/122.doc . G o o g l e crea automaticamente la versione .html dei documenti durante la scansione del Web. Per inserire un segnalibro o un collegamento alla pagina, utilizzare il seguente URL: http://www.google.com/search?q=cache:pUjj8wx3BhcJ:users.ox.ac.uk/~worc1440/122.doc+thyroid+cancer+filetype:pdf+OR+filetype:doc+OR+filetype:ppt+OR+filetype:xls+OR+filetype:rtf&hl=it&ct=clnk&cd=67&lr=lang_en Google non è collegato agli autori di questa pagina e non è responsabile del suo contenuto. I termini specificati sono presenti solamente in collegamenti che rimandano alla seguente pagina: thyroid cancer 1146 Thyroid Cancer Epidemiology: 1.5% of UK malignancies. 1400 new cases/yr. 300 deaths/yr. F>>M Presentation: >5% of thyroid nodules are cancer. 90% Goitre/Thyroid lump ...

Articles 2014 www.thelancet.com Vol 365 June 11, 2005 Introduction Modern combined-modality treatments have vastly improved survival for children with malignant disease, 1 and an understanding of the late effects of treatment is important for continued medical care. However, long-term survivors of those who had malignant disease in childhood have an increased incidence of subsequent primary thyroid cancer up to several decades after receiving radiotherapy for Hodgkin’s lymphoma, acute leukaemia, brain tumour, neuroblastoma, and non-Hodgkin’s lymphoma. 2–9 Most thyroid cancers are curable, but a second cancer in an individual surviving a first cancer is a substantial psychological and physical burden. The magnitude of risk of subsequent primary thyroid cancer over the range of radiotherapy doses is uncertain because dose-response ...

l del file contenuto in http://www.utmb.edu/otoref/grnds/Anaplastic-thyroid-Ca-050511/Anaplastic-thyroid-Ca-slides-050511.ppt . G o o g l e crea automaticamente la versione .html dei documenti durante la scansione del Web. Per inserire un segnalibro o un collegamento alla pagina, utilizzare il seguente URL: http://www.google.com/search?q=cache:0KnZWW8v2oQJ:www.utmb.edu/otoref/grnds/Anaplastic-thyroid-Ca-050511/Anaplastic-thyroid-Ca-slides-050511.ppt+thyroid+cancer+filetype:pdf+OR+filetype:doc+OR+filetype:ppt+OR+filetype:xls+OR+filetype:rtf&hl=it&ct=clnk&cd=7&lr=lang_en Google non è collegato agli autori di questa pagina e non è responsabile del suo contenuto. I termini specificati sono presenti solamente in collegamenti che rimandano alla seguente pagina: thyroid cancer 1581 ANAPLASTIC THYROID CANCER Sam J. Cunningham, MD, PhD Francis B. Quinn, Jr., MD UTMB Dept of Otolaryngology ...

tic) Gaucher’s disease that is a rare form, of which only a few cases have been reported. Morrison et al . 2 described 2 patients with asplenomegalic Gaucher’s disease in whom the presenting symptoms were pur- pura and anaemia respectively and the diagnosis was established only after bone marrow examination. The authors cited two more cases of Gaucher’s disease without splenomegaly. In a series of 34 patients, Matoth et al . 3 treated only one 9-year-old patient in whom the spleen was not palpable. In our series of more than 30 cases with Gaucher’s disease, we had one asplenomegalic patient. Since there is a correla- tion between the size of the spleen and the severity of the symptoms including the hematological findings, it is possible that some asymptomatic patients with Gaucher’s disease remain undiagnosed. With the introduction of enzyme replacement therapy, ...

All requested information must be provided to process registration. American Thyroid Association Frontiers in Thyroid Cancer: Clinical Care and REGISTRATION FORM Research for the Future Deadline for receipt of advance registration is April 7, 2005. Baltimore Marriott Waterfront Baltimore, Maryland April 14-17, 2005 All Fees are in US Dollars. __ First name __ Last name __ Nickname for badge Professional degree(s) (please list one): _ a. MD b. PhD c. MD, PhD d. RN e. Other __ Organization __ Address 1 __ Address 2 _ __ City State Zip code + 4 If outside the U.S., country/city code : __ Country (_)_ (_) Phone Fax __ E-mail address 1. I require ...